Matrix on Fruit Constituent Bioavailability

NCT ID: NCT01908634

Last Updated: 2021-02-11

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-07-01

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Primary objective is to evaluate the influence of matrix on the bioavailability of key phytochemical constituents in fruits and their subsequent effect on chronic disease risk factors.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is a single-center, randomized, cross-over, 4-arm, single- blinded, 6-hour postprandial study to evaluate the effects of strawberry or comparator fruit provided in a formulated beverage with milk (as the base) or water or fresh/pureed.

A planned sample size of 10 men and women will be recruited into the study. Subjects will be required to meet several inclusion and exclusion criteria, which will be assessed through online and clinic screening mechanisms, including questionnaires, fasting glucose concentration, and anthropometric measurements. Eligible subjects will be invited to participate in the study. Subjects will begin by completing a 3-day pre-study assessment of their usual dietary intake using 3-day food diary. After reviewing baseline food records, subjects will be instructed to avoid polyphenolic-containing foods for 2 days prior to the study visit, while maintaining their usual diet pattern and physical activity.

Subjects will participate in 6 h postprandial study days. Subjects will be randomized on the first day of starting the first post prandial visit day.

For each 6 h postprandial study visit, subjects will arrive fasted and follow procedures published by our lab previously. This includes: pre-study evaluation for compliance (fasting, dinner consumption, limited polyphenol intake) and readiness for study visit, catheter placement by registered nurse, fasting blood sample, consumption of high fat/carbohydrate meal accompanied by 1 of the treatment beverages, subsequent blood sampling from catheter \[ \~1 tablespoon (12ml)\] at designated time points for 6 hours.

Each postprandial study visit day will last approximately 7 hours and subjects will be required to remain at the Clinical Nutrition Research Center at the Illinois Institute of Technology main campus for the duration of the visit. The visit procedures are repeated four times \~ 1 week apart to accommodate subject testing with all four beverages; all procedures are identical on each postprandial study test visit with the exception that only an assigned test beverage per each visit will be consumed with the breakfast.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Non-smoker

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Milk-based Strawberry Beverage no meal

Milk-based Strawberry beverage without meal

Group Type ACTIVE_COMPARATOR

Milk-based Strawberry Beverage without meal

Intervention Type DIETARY_SUPPLEMENT

Water-based Strawberry Beverage no meal

Water-based Strawberry beverage without meal

Group Type EXPERIMENTAL

Water-Based Strawberry Beverage without meal

Intervention Type DIETARY_SUPPLEMENT

Milk-based strawberry Beverage with meal

Milk-based Strawberry beverage with meal

Group Type ACTIVE_COMPARATOR

Milk-based strawberry Beverage with meal

Intervention Type DIETARY_SUPPLEMENT

Water-based strawberry Beverage with meal

Water-based Strawberry beverage with meal

Group Type EXPERIMENTAL

Water-Based strawberry Beverage with meal

Intervention Type DIETARY_SUPPLEMENT

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Milk-based Strawberry Beverage without meal

Intervention Type DIETARY_SUPPLEMENT

Water-Based Strawberry Beverage without meal

Intervention Type DIETARY_SUPPLEMENT

Milk-based strawberry Beverage with meal

Intervention Type DIETARY_SUPPLEMENT

Water-Based strawberry Beverage with meal

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (18-78 years of age)
* Relatively healthy
* Non-smoker or past smoker with abstinence for at least 2 years

Exclusion Criteria

* Pregnant and/or breast feeding
* Smoker or past smoker with abstinence \<2 years
* Allergy or intolerance to study foods
* Current regular consumption of berries is \> 2 servings per day.
* Fasting blood glucose ≥ 126 mg/dL. Subjects identified with elevated fasting blood glucose levels will be advised to contact their primary care physician for appropriate follow-up care.
* Taking over the counter antioxidant supplements or other supplements that may interfere with the study procedures or endpoints.
* Subjects with unusual dietary habits (e.g. pica).
* Actively losing weight or trying to lose weight (unstable body weight fluctuations of \> 5 lbs in a 60 day period).
* Excessive exercisers or trained athletes.
* Subjects with documented atherosclerotic disease, inflammatory disease, diabetes mellitus, or other systemic diseases.
* Addicted to drugs and/or alcohol.
* Medically documented psychiatric or neurological disturbances.
* Severe obesity as defined by \>39.9 BMI or under weight for height (BMI \<18.5)
Minimum Eligible Age

18 Years

Maximum Eligible Age

78 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Clinical Nutrition Research Center, Illinois Institute of Technology

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Britt Burton-Freeman, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Illinois Institute of Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical Nutrition Research Center

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2013-076

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Silymarin Bioavailability Study
NCT06882681 COMPLETED NA